Quantitative RT-PCR: Prediction Lymphoma Transformation
Quantitative RT-PCR: Prediction Lymphoma Transformation
批准号:
6884253
负责人:
KOJO S. J. ELENITOBA-JOHNSON
金额:
$10.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-03-01 至 2006-09-01
关键词:
B cell lymphomaRNAbiotechnologyclinical researchcost effectivenessdiagnosis design /evaluationfluorescent dye /probegene expression profilinggenetic markershuman tissueionophoresmicroarray technologymolecular oncologyneoplasm /cancer classification /stagingneoplasm /cancer diagnosisneoplasm /cancer geneticsneoplastic growthnonHodgkin&aposs lymphomapolymerase chain reactionprognosis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Completion of the human genome and the advent of expression profiling have permitted comprehensive characterization of the transcriptional signatures of different disease states. Quantitative fluorescent real-time polymerase chain reaction-based methods have emerged as a powerful tool in molecular diagnostics as they combine extraordinary dynamic range of quantification and superior specificity. Despite the remarkable advances in real-time fluorescence quantification techniques, this technique has yet to gain widespread application in the analysis of gene expression fixed paraffin-embedded tissues, which is the most common way in which biopsy material is archived. In the R41 phase of this fast-track application, we will establish the utility of a simple approach to the performance of quantitative RT-PCR on RNA derived from formalin-fixed paraffinembedded tissue. The technique is advantageous in that it is simple and compatible with the design of PCR for short amplicons, without compromising target specificity. By the end of the R41 phase of this project, we would have established the feasibility, reproducibility and robustness of our quantitative real-time RT-PCR approach on RNA derived from formalin-fixed paraffin embedded tissue material. These studies will serve as the foundation for the gene expression profiling studies evaluating the predictive power of a previously identified set of ~30 genes to predict the transformation of follicular lymphoma to an aggressive large B-cell lymphoma in phase II.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
-
批准号:10655478
-
项目类别:
-
资助金额:$53.08万
-
财政年份:2022
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
-
批准号:10703746
-
项目类别:
-
资助金额:$51.11万
-
财政年份:2022
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Genomic biomarkers of splenic lymphoma
-
批准号:10703846
-
项目类别:
-
资助金额:$19.45万
-
财政年份:2022
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Genomic biomarkers of splenic lymphoma
-
批准号:10531857
-
项目类别:
-
资助金额:$62.15万
-
财政年份:2022
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Epiproteomics of Sezary Syndrome
-
批准号:10406932
-
项目类别:
-
资助金额:$13.46万
-
财政年份:2020
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Epiproteomics of Sezary Syndrome
-
批准号:10031052
-
项目类别:
-
资助金额:$61.04万
-
财政年份:2020
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Epiproteomics of Sezary Syndrome
-
批准号:10703845
-
项目类别:
-
资助金额:$52.87万
-
财政年份:2020
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Epiproteomics of Sezary Syndrome
-
批准号:10632068
-
项目类别:
-
资助金额:$56.66万
-
财政年份:2020
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Genomic biomarkers of splenic lymphoma
-
批准号:10312006
-
项目类别:
-
资助金额:$41.22万
-
财政年份:2020
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
-
批准号:10412096
-
项目类别:
-
资助金额:$2.49万
-
财政年份:2019
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
-
批准号:9817011
-
项目类别:
-
资助金额:$50.21万
-
财政年份:2019
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
-
批准号:10240270
-
项目类别:
-
资助金额:$47.33万
-
财政年份:2019
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma
-
批准号:8215896
-
项目类别:
-
资助金额:$27.77万
-
财政年份:2009
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma
-
批准号:7565662
-
项目类别:
-
资助金额:$28.92万
-
财政年份:2009
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma
-
批准号:8035900
-
项目类别:
-
资助金额:$27.87万
-
财政年份:2009
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Proteomic analysis of api2-MALT1 positive gastric MALT lymphoma
-
批准号:8458901
-
项目类别:
-
资助金额:$26.01万
-
财政年份:2009
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma
-
批准号:7530780
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2008
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma
-
批准号:7882577
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2008
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma
-
批准号:7663159
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2008
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
Mass spectrometry-driven systems biologic analysis of salivary MALT lymphoma
-
批准号:8118856
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2008
-
负责人:KOJO S. J. ELENITOBA-JOHNSON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
-
批准号:2026JJ50010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:应站明
-
依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
-
批准号:2026JJ81091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘亮
-
依托单位:
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程子译
-
依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
-
批准号:JCZRLH202600588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于基因编辑技术解析丹酚酸B靶向SAMHD1调控心肌线粒体RNA稳态干预心衰的分子机制研究
-
批准号:JCZRLH202601084
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
基于异质人群多源数据识别单细胞 RNA数量性状风险位点的统计学方法研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蔡铭轩
-
依托单位:
uN2CpolyG蛋白经ALYREF蛋白介导RNA转运异常在神经元核内包涵体病发病中的作用及机制研究
-
批准号:2026JJ60587
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张思哲
-
依托单位:
病毒非编码RNA多样性图谱构建及其生物发生与致病机制研究
-
批准号:2026JJ60389
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:傅萍
-
依托单位:
核糖核酸酶RNase E与其抑制因子RebA通过液-液相分离调控蓝藻RNA代谢的分子机制
-
批准号:JCZRQNB202600879
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: